Home Newsfeeds Wolfe Research Upgrades Warner Bros. Discovery to Outperform, Announces $20 Price Target

Wolfe Research Upgrades Warner Bros. Discovery to Outperform, Announces $20 Price Target

Wolfe Research analyst Peter Supino upgrades Warner Bros. Discovery (NASDAQ:WBD) from Peer Perform to Outperform and announces $20 price target.

byBenzinga Newsdesk

March 17, 2023

1 minute read

Wolfe Research analyst Peter Supino upgrades Warner Bros. Discovery (NASDAQ:WBD) from Peer Perform to Outperform and announces $20 price target.

News
Tech

Alphabet Unit Waymo Claims Lower Crash Rate Despite Regulator Probes Into Risky Driving Behavior: ‘This Is Why We Do It’

By Anan Ashraf

June 19, 3:05 AM

Waymo's self-driving technology beats human drivers in avoiding crashes and injuries. It has 3.5x fewer injuries and 2x fewer police-reported crashes.

GOOG

Warren Buffett Was Said To Overpay For BNSF Railway, Here’s Why He’s Having The Last Laugh

By Chris Katje

April 14, 10:24 AM

Legendary investor Warren Buffett is a fan of railroads, especially one of the leading railroad companies in North America, which is owned by Berkshire Hathaway Inc (NYSE: BRK-A)(NYSE: BRK-B).

AAPL

MindMed Calls FDA Experts To Validate LSD Drug Development Strategy

By Lara Goldstein

May 25, 2:52 PM

In a new chapter of the management quarrel between MindMed (NASDAQ: MNMD) executives and shareholder group FCM Holdings, t

MNMD

ZimVie Announces Compatibility Between Its Vital Spinal Fixation System And Brainlab Spine & Trauma Navigation

By Benzinga Newsdesk

December 12, 9:21 AM

ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced it has received FDA clearance for its Vital™ Spinal Fixation System including instruments for use with

ZIMV

Wolfe Research Upgrades Warner Bros. Discovery to Outperform, Announces $20 Price Target

Related Posts

Alphabet Unit Waymo Claims Lower Crash Rate Despite Regulator Probes Into Risky Driving Behavior: ‘This Is Why We Do It’

Warren Buffett Was Said To Overpay For BNSF Railway, Here’s Why He’s Having The Last Laugh

MindMed Calls FDA Experts To Validate LSD Drug Development Strategy

ZimVie Announces Compatibility Between Its Vital Spinal Fixation System And Brainlab Spine & Trauma Navigation